| Factors | No. | % | |
| Patients | 41 | 100.0 | |
| Age (mean) | 57.5 (30.8 - 82.3) | ||
| Pathological type | |||
| Ductal carcinoma | 32 | 78.0 | |
| Lobular carcinoma | 5 | 12.2 | |
| Mucinos carcinoma | 2 | 4.9 | |
| Unknown | 2 | 4.9 | |
| Nuclear grade | |||
| 1 | 2 | 6.3 | |
| 2 | 9 | 28.1 | |
| 3 | 21 | 65.6 | |
| Subtype | |||
| ER+/HER2+ | 3 | 7.3 | |
| ER+/HER2− | 10 | 24.4 | |
| ER−/HER2+ | 13 | 31.7 | |
| ER−/HER2− | 15 | 36.6 | |
| Tumor size | |||
| T1 | 4 | 9.8 | |
| T2 | 25 | 61.0 | |
| T3 | 4 | 9.8 | |
| T4 | 8 | 19.4 | |
| Lymph node metastasis | |||
| Negative | 11 | 26.8 | |
| Positive | 30 | 73.2 | |
| Stage (*1) | |||
| 2 | 18 | 43.9 | |
| 3 | 14 | 34.1 | |
| 4 | 9 | 22.0 | |
| Number of brain metastasis | |||
| 1 | 12 | 29.3 | |
| 1< | 29 | 70.7 | |
| ECOG PS | |||
| 0 | 8 | 19.5 | |
| 1 | 10 | 24.4 | |
| 2 | 9 | 22.0 | |
| 3 | 8 | 19.5 | |
| 4 | 6 | 14.6 | |